Genome Editing Applications

Informa's Genome Editing conference will showcase the most up-to-date therapeutic and biomedical applications emerging using CRISPRs, ZFNs, TALENs, AAVs and other genome engineering technologies. From improving lead discovery, validation of targeted cell lines and development of transgenic animal models to therapeutic uses in cell therapy & gene therapy.

A special emphasis on CRISPR will highlight the design of novel CRISPR constructs and discuss practical aspects of CRISPR including monitoring off-target effects, strategies to improve specificity and delivery to specific cell types, including potential applications in multigenic alterations.

By attending this applications focused conference you will learn about advances in all of the latest genome editing technologies, including comparisons, advantages and disadvantages of each. You will also learn how to position your company for success in genome editing in the face of the still-evolving IP landscape of CRISPR and other genome editing approaches.

TJ Cradick, CRISPR Therapeutics, Philippe Duchateau, Cellectis, Myung Shin, Merck & Co., Ines Royaux, Janssen Pharmaceutica NV., Lorenz Mayr, AstraZenica, William Skarnes, The Wellcome Trust Sanger Institute, Charles Gersbach, Duke University, Victor Bartsevich, Precision Biosciences, Inc.

• Conferences & Trade Shows Today